South Africa: The First Generic Weight Loss Drug Hit South Africa In August - With Many Expected To Follow. Will It Be Enough To Kill The Black Market?

South Africa saw the introduction of its first generic semaglutide injection in August, marking the beginning of an expected wave of similar weight loss drug alternatives entering the market. These GLP-1 receptor agonists are part of a growing class of medications used for weight management.

The arrival of these generic options is anticipated to increase market competition, potentially lowering the high costs currently associated with branded blockbuster drugs. Analysts are now evaluating whether these price reductions will be sufficient to undermine the illicit black market for these medications and whether the drugs will become accessible enough for distribution within the public health sector.